Link Securities | Laboratorios Reig Jofre (RJF) has informed the CNMV that it has reached an important milestone together with its partner Maruishi Pharmaceutical in Japan: the production in Barcelona and commercialisation in Japan of 15 million vials of the anaesthetic Remifentanil, a latest generation intravenous anaesthetic for hospital use. This product, developed internally by the company, is produced in RJF’s sterile and lyophilised injectables plant. RJF’s plants are responsible…